Medicare Enrolled

Dr. Dhiman Basu, MD

Internal Medicine · Colleyville, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
5009 HERITAGE AVE, Colleyville, TX 76034
8175900880
In practice since 2007 (19 years)
NPI: 1336266964 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Basu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Basu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Basu

Dr. Dhiman Basu is an internal medicine in Colleyville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Basu performed 72,122 Medicare services across 491 unique beneficiaries.

Between the years covered by Open Payments, Dr. Basu received a total of $1,759,063 from 72 pharmaceutical and/or device companies across 4466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Basu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in TX$ $1,759,063 industry payments

Medicare Practice Summary

Medicare Utilization ↗
72,122
Medicare services
Top 1% in TX for internal medicine
491
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,796 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)54,800$4$13
Abatacept infusion (Orencia)8,700$30$96
Denosumab injection (Prolia/Xgeva)4,260$17$53
Infliximab infusion (Remicade)2,560$26$86
Office visit, established patient (30-39 min)836$91$270
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle447$53$189
Administration of chemotherapy into vein, 1 hour or less252$96$345
Steroid injection (triamcinolone)118$1$15
Administration of chemotherapy into vein, each additional hour96$22$110
Aspiration and/or injection of fluid large joint using ultrasound guidance30$62$233
New patient office visit (45-59 min)23$118$415
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.6% high complexity
83.2% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,759,063
Total received (2018-2024)
Avg $251,295/year across 7 years
Top 0% in TX for internal medicine
72
Companies
4,466
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,616,273 (91.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$130,307 (7.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,483 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$294,916
2023
$309,627
2022
$263,943
2021
$231,649
2020
$119,148
2019
$312,538
2018
$227,242

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$245,719
Lilly USA, LLC
$149,001
Novartis Pharmaceuticals Corporation
$126,539
Aurinia Pharma U.S., Inc.
$114,313
AstraZeneca Pharmaceuticals LP
$108,827
Mallinckrodt Hospital Products Inc.
$104,731
Mallinckrodt Enterprises LLC
$95,535
Janssen Scientific Affairs, LLC
$83,149
GlaxoSmithKline, LLC.
$82,828
Alexion Pharmaceuticals, Inc.
$74,488
UCB, Inc.
$68,695
GENZYME CORPORATION
$57,840
ANI Pharmaceuticals, Inc.
$57,133
Janssen Biotech, Inc.
$53,220
AbbVie, Inc.
$42,189
ABBVIE INC.
$39,940
PFIZER INC.
$37,598
Celgene Corporation
$35,565
AbbVie Inc.
$33,126
Ironwood Pharmaceuticals, Inc
$25,995
Mallinckrodt LLC
$21,391
Genentech USA, Inc.
$18,898
Kyowa Kirin, Inc.
$14,789
Sandoz Inc.
$10,889
Horizon Therapeutics plc
$9,617
Exeltis, USA Inc.
$8,886
E.R. Squibb & Sons, L.L.C.
$7,511
Gilead Sciences, Inc.
$5,253
UCB SA
$5,012
Regeneron Healthcare Solutions, Inc.
$4,508
Pfizer Inc.
$3,597
Octapharma USA, Inc.
$3,085
Regeneron Pharmaceuticals, Inc.
$3,030
Horizon Pharma plc
$1,931
SANOFI-AVENTIS U.S. LLC
$914
Radius Health, Inc.
$582
Genentech, Inc.
$358
Boehringer Ingelheim Pharmaceuticals, Inc.
$287
Antares Pharma, Inc.
$193
Organon LLC
$187
Takeda Pharmaceuticals U.S.A., Inc.
$168
Arbor Pharmaceuticals, Inc.
$162
Organon Llc
$161
ARBOR PHARMACEUTICALS, INC.
$138
AstraZeneca UK Limited
$135
Sobi, Inc
$103
Alnylam Pharmaceuticals Inc.
$103
Actelion Pharmaceuticals US, Inc.
$69
Hikma Pharmaceuticals USA
$60
Kiniksa Pharmaceuticals International, plc
$54
Ultragenyx Pharmaceutical Inc.
$53
Pacira Pharmaceuticals Incorporated
$53
Zyla Life Sciences
$50
Kiniksa Pharmaceuticals, Ltd.
$43
Bioventus LLC
$31
Flexion Therapeutics, Inc.
$30
MEDEXUS PHARMA, INC.
$28
Purdue Pharma L.P.
$28
MEDAC PHARMA, INC.
$27
Mission Pharmacal Company
$25
Ferring Pharmaceuticals Inc.
$23
Eisai Inc.
$21
DePuy Synthes Sales Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$18
West-Ward Pharmaceuticals
$18
Fresenius Kabi USA, LLC
$16
Assertio Therapeutics, Inc.
$14
Celltrion USA Inc.
$14
SI-BONE, Inc.
$13
Vertical Pharmaceuticals, LLC
$13
Azurity Pharmaceuticals, Inc.
$13
ASSERTIO THERAPEUTICS, Inc.
$12
Top 3 companies account for 29.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · Binosto · COSENTYX · CYLTEZO · Cambia · Cimzia · Crysvita · DUZALLO · Dayvigo · ERELZI · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · GELSYN-3 · GIVLAARI · HADLIMA · HUMIRA · HYQVIA · Horizant · Humira · IDACIO · ILARIS · Iovera · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kerendia · Kineret · LINZESS · LORZONE · LUPKYNIS · LYRICA · Mitigare · NEXPLANON · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYMPROIC · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · UPTRAVI · Uloric · XELJANZ · XYOSTED · YUFLYMA · ZIPSOR · ZORVOLEX · Zilretta · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.

Equivalent to $2,439 per 100 Medicare services performed
Looking for a internal medicine in Colleyville?
Compare internal medicines in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
2,347
Per 100K population
109.9
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Basu is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Basu experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Basu performed 54,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Basu receive payments from pharmaceutical companies?
Yes. Dr. Basu received a total of $1,759,063 from 72 companies across 4,466 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Basu's costs compare to other internal medicines in Colleyville?
Dr. Basu's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Basu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →